Evidence map›Paper›PMID 25737331›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2015

High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey.

Clare Tanton, Kate Soldan, Simon Beddows, Catherine H Mercer, Jo Waller, Nigel Field, Soazig Clifton, Andrew J Copas, Kavita Panwar, Precious Manyenga and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Clare TantonResearch Department of Infection and Population Health, University College London, London, United Kingdom. c.tanton@ucl.ac.uk.
Kate SoldanCentre for Infectious Disease Surveillance & Control (CIDSC), Public Health England, London, United Kingdom.
Simon BeddowsVirus Reference Department, Public Health England, London, United Kingdom.
Catherine H MercerResearch Department of Infection and Population Health, University College London, London, United Kingdom.
Jo WallerCancer Research UK Health Behaviour Research Centre, Research Department of Epidemiology and Public Health, University College London, London, United Kingdom.
Nigel FieldResearch Department of Infection and Population Health, University College London, London, United Kingdom.
Soazig CliftonResearch Department of Infection and Population Health, University College London, London, United Kingdom. NatCen Social Research, London, United Kingdom.
Andrew J CopasResearch Department of Infection and Population Health, University College London, London, United Kingdom.
Kavita PanwarVirus Reference Department, Public Health England, London, United Kingdom.
Precious ManyengaVirus Reference Department, Public Health England, London, United Kingdom.
Filomeno da SilvaVirus Reference Department, Public Health England, London, United Kingdom.
Kaye WellingsCentre for Sexual and Reproductive Health Research, Department of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Catherine A IsonSexually Transmitted Bacteria Reference Unit, Public Health England, London, United Kingdom.
Anne M JohnsonResearch Department of Infection and Population Health, University College London, London, United Kingdom.
Pam SonnenbergResearch Department of Infection and Population Health, University College London, London, United Kingdom.
University College London · GB

Funding

Department of HealthMedical Research Council G0701757Wellcome Trust 084840
6 · The paper itself

Abstract

backgroundThe third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3) provides an opportunity to explore high-risk human papillomavirus (HR-HPV) and uptake of cervical screening and HPV vaccination in the general population.

methodsNatsal-3, a probability sample survey of men and women ages 16 to 74, resident in Britain, interviewed 8,869 women in 2010 to 2012. We explored risk factors for HR-HPV (in urine from 2,569 sexually experienced women ages 16 to 44), nonattendance for cervical screening in the past 5 years, and noncompletion of HPV catch-up vaccination.

resultsHR-HPV was associated with increasing numbers of lifetime partners, younger age, increasing area-level deprivation, and smoking. Screening nonattendance was associated with younger and older age, increasing area-level deprivation (age-adjusted OR 1.91, 95% confidence interval, 1.48-2.47 for living in most vs. least deprived two quintiles), Asian/Asian British ethnicity (1.96, 1.32-2.90), smoking (1.97, 1.57-2.47), and reporting no partner in the past 5 years (2.45, 1.67-3.61 vs. 1 partner) but not with HR-HPV (1.35, 0.79-2.31). Lower uptake of HPV catch-up vaccination was associated with increasing area-level deprivation, non-white ethnicity, smoking, and increasing lifetime partners.

conclusionsSocioeconomic markers and smoking were associated with HR-HPV positivity, nonattendance for cervical screening, and noncompletion of catch-up HPV vaccination. IMPACT: The cervical screening program needs to engage those missing HPV catch-up vaccination to avoid a potential widening of cervical cancer disparities in these cohorts. As some screening nonattenders are at low risk for HR-HPV, tailored approaches may be appropriate to increase screening among higher-risk women.

Indexed as

AdolescentAdultAgedFemaleHealth SurveysHumansMass ScreeningMiddle AgedPapillomaviridaePapillomavirus InfectionsPapillomavirus VaccinesProbabilityRisk FactorsSmokingSocioeconomic FactorsUnited KingdomPapillomavirus Vaccines

Identifiers

PMID25737331
PMCPMC4435666
OpenAlexW2125014797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.